Dr Martens PLC
LSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (9.5), the stock would be worth GBX73.29 (14% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.3 | GBX64.2 |
0%
|
| 3-Year Average | 9.5 | GBX73.29 |
+14%
|
| 5-Year Average | 10.7 | GBX83.07 |
+29%
|
| Industry Average | 0.1 | GBX0.84 |
-99%
|
| Country Average | 0 | GBX0.23 |
-100%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
GBX921m
|
/ |
Sep 2025
£105.1m
|
= |
|
|
GBX921m
|
/ |
Mar 2026
£79m
|
= |
|
|
GBX921m
|
/ |
Mar 2027
£96.1m
|
= |
|
|
GBX921m
|
/ |
Mar 2028
£109.8m
|
= |
|
|
GBX921m
|
/ |
Mar 2029
£120.5m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Dr Martens PLC
LSE:DOCS
|
620.4m GBP | 8.3 | 40.3 | |
| US |
|
Nike Inc
NYSE:NKE
|
65.4B USD | 22.9 | 29.1 | |
| JP |
|
Asics Corp
TSE:7936
|
3.1T JPY | 21 | 30.9 | |
| US |
|
Deckers Outdoor Corp
NYSE:DECK
|
14B USD | 9.3 | 13.5 | |
| CH |
|
On Holding AG
NYSE:ONON
|
10.9B USD | 21.3 | 42.5 | |
| US |
|
Skechers USA Inc
NYSE:SKX
|
9.5B USD | 9.9 | 14.3 | |
| CN |
|
Huali Industrial Group Co Ltd
SZSE:300979
|
51.8B CNY | 10.6 | 15 | |
| UK |
|
Birkenstock Holding PLC
NYSE:BIRK
|
6.4B USD | 11.6 | 14.3 | |
| US |
|
Crocs Inc
NASDAQ:CROX
|
4.2B USD | 5.8 | -51.7 | |
| DE |
|
Puma SE
XETRA:PUM
|
3.2B EUR | -11.9 | -5 | |
| HK |
|
Yue Yuen Industrial (Holdings) Ltd
HKEX:551
|
24.6B HKD | 6.3 | 8.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0.1 |
| Max | 1 015 |
Other Multiples
Dr Martens PLC
Glance View
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. The company offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. The company operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
